Earnings Per Share, Basic of Deciphera Pharmaceuticals, Inc. from 30 Jun 2020 to 31 Mar 2024
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
Deciphera Pharmaceuticals, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Jun 2020 to 31 Mar 2024.
- Deciphera Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending 31 Mar 2024 was -0.52, a 13% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending 31 Mar 2024 was -2, a 1.8% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -2.29, a 3.4% increase from 2022.
- Deciphera Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -2.37, a 54% increase from 2021.
- Deciphera Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -5.16, a 8% decline from 2020.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
Deciphera Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2024 | -2 | -0.52 | +0.08 | +13% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 10 May 2024 | 2024 | Q1 |
| Q4 2023 | -2 | -0.54 | -0.12 | -29% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 07 Feb 2024 | 2023 | FY |
| Q3 2023 | -2 | -0.58 | -0.03 | -5.5% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 30 Oct 2023 | 2023 | Q3 |
| Q2 2023 | -2 | -0.57 | +0.03 | +5% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 09 Aug 2023 | 2023 | Q2 |
| Q1 2023 | -2 | -0.6 | +0.2 | +25% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 10 May 2024 | 2024 | Q1 |
| Q4 2022 | -2 | -0.42 | +1.1 | +72% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 07 Feb 2024 | 2023 | FY |
| Q3 2022 | -3 | -0.55 | +0.82 | +60% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 30 Oct 2023 | 2023 | Q3 |
| Q2 2022 | -4 | -0.6 | +0.61 | +50% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 09 Aug 2023 | 2023 | Q2 |
| Q1 2022 | -5 | -0.8 | +0.26 | +25% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 03 May 2023 | 2023 | Q1 |
| Q4 2021 | -5 | -1.52 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 07 Feb 2024 | 2023 | FY | ||
| Q3 2021 | -1.37 | -0.24 | -21% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 03 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | -1.21 | -0.01 | -0.83% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 04 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | -1.06 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 04 May 2022 | 2022 | Q1 | |||
| Q3 2020 | -1.13 | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 02 Nov 2021 | 2021 | Q3 | |||
| Q2 2020 | -1.2 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 03 Aug 2021 | 2021 | Q2 |
Deciphera Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2023 | -2.29 | +0.08 | +3.4% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 07 Feb 2024 | 2023 | FY |
| 2022 | -2.37 | +2.79 | +54% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 07 Feb 2024 | 2023 | FY |
| 2021 | -5.16 | -0.38 | -8% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 07 Feb 2024 | 2023 | FY |
| 2020 | -4.78 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 07 Feb 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.